Background/Objectives: Bupleuri Radix is a plant in the Apiaceae family Bupleurum Chinense DC. or Bupleurum scorzonerifolium Willd. root. The dissimilarities in the metabolite profiles of plants directly correlate with the disparities in their clinical efficacy. Methods: Therefore, the wild Bupleurum Chinense DC. (YBC) and wild Bupleurum scorzonerifolium Willd. (YNC) were used as research materials. They were analyzed using the UPLC-MS/MS and the similarities and differences were uncovered based on differential metabolites. Results: Our results proved that the differences in clinical efficacy between YBC and YNC may be attributed to their distinct metabolite profiles, as follows: (1) a total of 12 classes of 2059 metabolites were identified in the roots, with phenolic acids, terpenoids, and flavonoids being the most abundant metabolic products, with 2026 shared components between the two, 2045 in YBC, and 2040 in YNC; (2) a total of 718 differential metabolites were identified, accounting for 35.44% of the shared metabolites. Among them, YBC had 452 metabolites with higher content relative to YNC, representing 62.95%, and 266 components with lower content, representing 37.05%; (3) the KEEG enrichment analysis results show that the differential metabolic pathways are flavone and flavonol biosynthesis, linoleic acid metabolism, arachidonic acid metabolism, sesquiterpenoid and triterpenoid biosynthesis, and linolenic acid metabolism. Conclusions: These new findings will serve as a foundation for further study of the BR biosynthetic pathway and offer insights into the practical use of traditional Chinese medicine in clinical settings.
The large-scale cultivation of medicinal plants generates substantial agricultural by-products that are often discarded. A notable example is the floral biomass of Bupleurum chinense DC. (B. chinense), which is routinely removed during cultivation to promote root yield. To explore the potential valorization of these discarded tissues, we performed an integrated transcriptomic and metabolomic analysis of flavonoid biosynthesis across three developmental stages: F1 (Initial Flowering Stage), F2 (Full Bloom Stage), and F3 (Late Flowering Stage). Our results revealed distinct stage-specific regulatory dynamics. Flavonoid biosynthesis was initiated at F1 through the activation of upstream structural genes, reached its peak at F2 with strong up-regulation of branch-specific genes and the accumulation of diverse flavonols and anthocyanins, and declined at F3, despite the sustained presence of several antioxidant metabolites. These findings indicate that F2 represents the optimal stage for harvesting B. chinense flowers to obtain a broad spectrum of bioactive flavonoids, while late-stage flowers may serve as a complementary source of stable antioxidant compounds. Collectively, this study highlights the potential for transforming discarded floral biomass into valuable phytochemical resources and provides a framework for exploring underutilized tissues in other medicinal plants.